InvestorsObserver
×
News Home

Is Apyx Medical Corp (APYX) a Good Buy in the Medical Devices Industry?

Friday, October 01, 2021 12:01 PM | InvestorsObserver Analysts

Mentioned in this article

Is Apyx Medical Corp (APYX) a Good Buy in the Medical Devices Industry?

The 65 rating InvestorsObserver gives to Apyx Medical Corp (APYX) stock puts it near the top of the Medical Devices industry. In addition to scoring higher than 88 percent of stocks in the Medical Devices industry, APYX’s 65 overall rating means the stock scores better than 65 percent of all stocks.

Overall Score - 65
APYX has an Overall Score of 65. Find out what this means to you and get the rest of the rankings on APYX!

What do These Ratings Mean?

Trying to find the best stocks can be a daunting task. There are a wide variety of ways to analyze stocks in order to determine which ones are performing the strongest. InvestorsObserver makes the entire process easier by using percentile rankings that allows you to easily find the stocks who have the strongest evaluations by analysts. These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.

What's Happening With Apyx Medical Corp Stock Today?

Apyx Medical Corp (APYX) stock is down -0.43% while the S&P 500 is up 0.54% as of 11:57 AM on Friday, Oct 1. APYX is lower by -$0.06 from the previous closing price of $13.85 on volume of 80,237 shares. Over the past year the S&P 500 is higher by 28.10% while APYX is up 184.33%. APYX lost -$0.41 per share the over the last 12 months. Click Here to get the full Stock Report for Apyx Medical Corp stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App